Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease.

MLA

Martier, Raygene, et al. “Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease.” Molecular Therapy. Methods & Clinical Development, vol. 15, Oct. 2019, pp. 343–58. EBSCOhost, https://doi.org/10.1016/j.omtm.2019.10.008.

APA

Martier, R., Sogorb-Gonzalez, M., Stricker-Shaver, J., Hübener-Schmid, J., Keskin, S., Klima, J., Toonen, L. J., Juhas, S., Juhasova, J., Ellederova, Z., Motlik, J., Haas, E., van Deventer, S., Konstantinova, P., Nguyen, H. P., & Evers, M. M. (2019). Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease. Molecular Therapy. Methods & Clinical Development, 15, 343–358. https://doi.org/10.1016/j.omtm.2019.10.008

Chicago

Martier, Raygene, Marina Sogorb-Gonzalez, Janice Stricker-Shaver, Jeannette Hübener-Schmid, Sonay Keskin, Jiri Klima, Lodewijk J Toonen, et al. 2019. “Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease.” Molecular Therapy. Methods & Clinical Development 15 (October): 343–58. doi:10.1016/j.omtm.2019.10.008.